Jacobson Pharma
Unit 2313-18, 23/F, Tower 1 Millennium City 1
388 Kwun Tong Road
Kwun Tong
Kowloon
Tel: 852-2267-2298
Website: http://www.jacobsonpharma.com/
Email: corp.comm@jacobsonpharma.com
About Jacobson Pharma
Jacobson Pharma Corporation Limited is a leading pharmaceutical company with the largest number of licensed production facilities for generic drugs in Hong Kong.We are the largest provider of generic drugs for both public and private sectors in terms of our market shares in Hong Kong and have established a pre-eminent market position through our leading position in a growing number therapeutic categories, as well as our capabilities in distribution, research and development.
Our broad and diversified product portfolio represents over 60%* of all product licenses granted to generic drug manufacturers in Hong Kong.
LEADERSHIP:
CEO: Sum Kwong Yip
JOBS:
Please click here for Jacobson job opportunities.
PRODUCTS:
All Products
6 articles about Jacobson Pharma
-
Jacobson Pharma Enters Agreements With Henlius Biotech Inc. to Tap Biologics Market
12/21/2017
Under the licensing Framework Agreement, Jacobson Medical will be granted an exclusive right to develop and market a propriety biosimilar product of Shanghai Henlius in Hong Kong and Macau for a period of 10 years
-
Jacobson Pharma Announces FY2018 Interim Results
11/22/2017
During the Reporting Period, the Group's revenue increased by 29.1% to HK$743.0M.
-
Hong Kong's Jacobson Pharma Raises $64 Million For M&A
10/6/2017
-
Jacobson Pharma Completes Issue Of HK$500 Million Of Convertible Notes To Dragons 615 Limited And HH Inre JP, Ltd.
10/5/2017
-
Jacobson Pharma Announces 2017 Annual Results
6/27/2017
-
Jacobson Pharma, A Hong Kong Generic Drugmaker, Stages $85 Million IPO
9/21/2016